Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc add-on therapy and microbial translocation in HIV-1 infected individuals on ART
2010-023625-38Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of maraviroc in Human immunodeficiency virus infection type 1, sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Microbial translocation (primary). Started Apr 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2010-023625-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023625-38.